Aliasgar Moiyadi

Further involvements

• 14/09/2023

  • ePoster
  • eP-NO-A117

  Immunohistochemical expression of H3K27me3 protein in IDH-mutant gliomas
• 14/09/2023

  • ePoster
  • eP-NO-A96

  POST (Preview Of Spinal Tumours) study
• 14/09/2023

  • ePoster
  • eP-NO-A126

  Evaluation of 1p deletion by Fluorescence in situ Hybridization in meningiomas – a simple easy to implement prognostic stratifier
• 14/09/2023

  • ePoster
  • eP-NO-A110

  MGMT gene promoter methylation in diffuse midline glioma, H3K27-mutant
• 14/09/2023

  • ePoster
  • PS6-NO-A63

  Adult medulloblastoma – clinico-molecular spectrum, an institutional experience
• 14/09/2023

  • ePoster
  • PS6-NO-A61

  Gliomas with immunohistochemical loss of MMR proteins – clinico-pathological evaluation, a tertiary care cancer institute experience
• 15/09/2023

  13:09 – 13:15 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A61

  Gliomas with immunohistochemical loss of MMR proteins – clinico-pathological evaluation, a tertiary care cancer institute experience
• 15/09/2023

  13:21 – 13:27 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A63

  Adult medulloblastoma – clinico-molecular spectrum, an institutional experience
• 15/09/2023

  17:40 – 17:50 7 Min. 3 Min.

  • Abstract Talk
  • S24-NO-A14

  CDKN2A/B deletion in IDH-mutant astrocytomas